Atlas with annotated neuropathology images launched

Schmidt Robert Schmidt, MD, PhD, a professor of pathology and immunology at Washington University School of Medicine in St. Louis, has curated a collection of more than 33,000 individually annotated neuropathology images that are now available as a resource to the...

Imaging technique shows new details of peptide structures

A new imaging technique developed by engineers at Washington University in St. Louis can give scientists a much closer look at fibril assemblies — stacks of peptides that include amyloid beta, most notably associated with Alzheimer’s disease. These cross-β fibril...

Role of dust on indoor environmental air quality gets closer look

House dust is an ever-present nuisance. The persistent substance is made up of a variety of particles, including dead skin cells, pet dander and airborne pollutants that settle onto and stick to dust particles, creating a risk to human health. Jenna Ditto, an...

Mahmoud honored by American Heart Association

Mahmoud Zainab Mahmoud, MD, an instructor in medicine at Washington University School of Medicine in St. Louis, has been awarded the Dr. Nanette K. Wenger Research Goes Red Award from the American Heart Association. Presented annually, the award recognizes what is...

$6.2 million to help develop gene therapy for HIV

HIV infections can be controlled with medication, but such therapy must continue throughout patients’ lives because no strategy exists to eliminate the virus from the body or control the infection without ongoing treatment. With the aim of developing such a strategy,...

Nine WashU faculty elected to AAAS

Nine faculty members at Washington University in St. Louis are among the 502 new fellows selected by the American Association for the Advancement of Science (AAAS), one of the most distinct honors in the scientific community. The 2023 class includes: Deanna Barch,...

Alzheimer’s disease progresses faster in people with Down syndrome

Nearly all adults with Down syndrome will develop evidence of Alzheimer’s disease by late middle age. A new study by researchers at Washington University School of Medicine in St. Louis shows that the disease both starts earlier and moves faster in people with Down...

Epilepsy drug prevents brain tumors in mice with NF1

A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis. NF1 is a genetic condition that...